Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105175317A reveals advanced sodium picosulfate synthesis with high yield. Discover supply chain advantages and cost reduction in pharmaceutical manufacturing.
Patent CN117402085A reveals high-yield route for Sacubitril intermediate. Reduces cost and improves supply chain reliability for global pharma manufacturers.
Patent CN105273023B enables high-purity cytarabine prodrug synthesis without chromatography ensuring cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113087691A details a Pd-catalyzed kinetic resolution for chiral aryl tertiary alcohols. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Efficient preparation of Eltrombopag intermediate via palladium-free cyclization reducing costs and environmental impact for API manufacturing.
Patent CN1027503C details a superior crystalline salt form of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenzo[cd]indole, offering enhanced purity and scalable manufacturing for CNS drug development.
Novel patent CN118459486A enables high-purity crisaborole impurity synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced preparation method for high-purity Imatinib exceeding 99.5% purity. Optimized solvent recycling and mild conditions ensure cost reduction in pharmaceutical manufacturing.
Novel one-pot synthesis of difluoromethylsulfurized flavonoids via patent CN110294730A. Reduces cost and simplifies supply chain for pharmaceutical intermediates.
Discover the organocatalytic synthesis of chromanone spiro indole intermediates. A cost-effective, metal-free route for oncology drug discovery and development.
Patent CN108473418A reveals a safer chiral resolution method for sulfonamide derivatives. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN111320577A reveals a scalable 5-step synthesis for Vadadustat intermediates, eliminating column chromatography and significantly reducing manufacturing costs for pharmaceutical supply chains.
Novel titanium-catalyzed oxidation method ensures high purity esomeprazole intermediates with scalable industrial production capabilities for global supply chains.
Explore the novel synthesis of N-substituted thiomorpholine derivatives for diabetes treatment. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity DPP-IV inhibitors.
Novel Reformatsky route enhances purity and scalability for voriconazole intermediate manufacturing, reducing costs and ensuring supply chain reliability for global pharma partners.
Novel DBU ionic liquid catalytic system for diaryl acetylene from calcium carbide. Enhances safety and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN109810009B details a safer, cost-effective route for L-thyroxine sodium using inorganic bases, offering supply chain stability for pharmaceutical manufacturers.
Patent CN118978462A reveals a green N-S coupling method. It offers high yield and selectivity for sulfonamide derivatives, ensuring cost reduction and supply reliability.
Patent CN112479946B details a novel organocatalytic route for D-p-methylsulfonyl phenylserine ethyl ester, offering improved stereoselectivity and cost efficiency for florfenicol manufacturing.
Novel bicarbonate-mediated carbamate formation for Capecitabine. High yield, simplified purification, cost-effective API intermediate manufacturing.